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BACKGROUND: The optimal approach to managing hyperglycemia in noncritically ill hospital patients is unclear.
OBJECTIVE: To investigate the effects of targeted quality improvement interventions on insulin prescribing and glycemic
control.
DESIGN: A cohort study comparing an intervention group (IG) to a concurrent control group (CCG) and an historic control
group (HCG).
SETTING: University of Michigan Hospital.
PATIENTS: Hyperglycemic, noncritically ill hospital patients treated with insulin.
INTERVENTION: Physician and nurse education and a standardized insulin order form based on the principles of physiologic
insulin use.
MEASUREMENTS: Glycemic control and insulin prescribing patterns.
RESULTS: Patients in the IG were more likely to be treated with a combination of scheduled basal and nutritional insulin than in
the other groups. In the final adjusted regression model, patients in the IG were more likely to be in the target glucose range
(odds ratio [OR], 1.72; P¼ 0.01) and less likely to be severely hyperglycemic (OR, 0.65; P< 0.01) when compared to those in the
CCG. Patients in the IG were also less likely to experience hypoglycemia than those in the CCG (P¼ 0.06) or the HCG (P¼ 0.01).
Over 80% of all patient-days for all groups contained glucose readings outside of the target range.
CONCLUSIONS: Standardized interventions encouraging the physiologic use of subcutaneous insulin can lead to significant
improvements in glycemic control and patient safety in hospitalized patients. However, the observed improvements are
modest, and poor metabolic control remains common, despite these interventions. Additional research is needed to
determine the best strategy for safely achieving metabolic control in these patients. Journal of Hospital Medicine
2010;5:438–445. VC 2010 Society of Hospital Medicine.
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Hyperglycemia is common in hospitalized patients, and
hyperglycemia has been associated with poor hospital out-
comes. The adverse physiologic effects of acute hyperglyce-
mia are well established1 and several clinical studies have
linked hyperglycemia with poor clinical outcomes in certain
patient populations.2–8 Although the optimal target range
for inpatient glycemic control has not yet been defined,
these studies support the goal of metabolic control for hos-
pital patients. However, there are many barriers to achieving
adequate glycemic control in the hospital, and blood gluco-
ses in the hospital are often far from recommended tar-
gets.9,10 One barrier appears to be the low priority given to
glycemic control in the hospital. Hyperglycemia in the hos-
pital is often ignored,11 and insulin regimens are often cho-
sen for simplicity as opposed to effectiveness.12 Other bar-
riers to glycemic control in the hospital include the
physiologic effects (‘‘stress’’) of acute illness, and the fre-
quent nutritional changes and interruptions that occur.
Most hyperglycemic patients on a general medicine unit
are treated with subcutaneous insulin, but the optimal
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strategy for prescribing insulin in the hospital remains
uncertain. A technical review of the literature on the man-
agement of diabetes in the hospital setting from 2004 rec-
ommends prescribing insulin in a way that mimics physio-
logic insulin secretion (ie, physiologic or ‘‘basal-bolus’’
insulin).1 This approach has been promulgated by experts,
but there has been very little research to support these rec-
ommendations. One small, randomized trial concluded that
a basal-bolus approach achieved better glycemic control
than the use of sliding-scale insulin alone,13 and 2 quality
improvement studies using a before/after design have dem-
onstrated improvements in glycemic control after the imple-
mentation of interventions designed to encourage physio-
logic insulin use.14,15
In this study we hypothesized that a few simple interven-
tions (education for physicians and nurses, and a standar-
dized insulin order form) would lead to a higher rate of ba-
sal-bolus insulin use and simultaneously improve glycemic
control and patient safety.
Methods
Study Design
This study was performed at the University of Michigan
Hospital over a 6-month period, and the protocol was
approved by the Institutional Review Board. We performed a
quasi-experimental study comparing 3 patient groups. The
intervention group (IG) was subject to all of the interven-
tions discussed below (physician education, nurse educa-
tion, and the standardized order form). The concurrent con-
trol group (CCG) was hospitalized during the same time
period as the IG, but was only subject to 1 of the interven-
tions (physician education). These patients were cared for
by the same physicians as the IG, but on a different unit
where the nurses had not received the education and where
the standardized insulin order form was not available.
Patients were admitted to the IG unit or the CCG unit via
the institution’s usual admission process. In addition, we
examined an historic control group (HCG) which was hospi-
talized during the same months of the year, but 2 years
prior. The HCG was not subject to any of the interventions.
Interventions
Standardized Subcutaneous Insulin Order Form: This form
(Supporting Information Appendix 1) was designed to en-
courage physicians to prescribe insulin in a physiologic way,
providing basal, nutritional, and correctional insulin. The
form is based on ‘‘best practice’’ guidelines,1 and is in agree-
ment with the principles of the inpatient management of di-
abetes and hyperglycemia endorsed by several professional
organizations.16,17 The form was engineered by a multidisci-
plinary team, including an endocrinologist, several hospital-
ists, several nurses, a certified diabetes educator, a pharma-
cist, and others. It is derived from the extensive experience
of the University of Michigan Hospital Intensive Insulin Pro-
gram (HIIP) in the Division of Endocrinology, and on work
done by the Society of Hospital Medicine (SHM) Glycemic
Control Task Force.17–19 This form was only used in the care
of patients in the IG. The form, which was not approved for
use on other floors, did not ‘‘creep’’ to other units. The
standardized order form was the only way to order insulin
or to modify the insulin regimen on the IG unit. The fre-
quency of review or revision of the insulin orders was left to
the discretion of the inpatient physicians.
Physician/Midlevel Provider Education: Physicians and midle-
vel providers caring for patients in the IG and the CCG were
given specific education about the ‘‘best practice’’ recom-
mendations for the management of diabetes and hypergly-
cemia in hospitalized patients. This education was based on
the principles of anticipatory, physiologic insulin use. On
nonhouse staff services, the education was provided to the
attending physicians and midlevel providers, and on house
staff services, the education was provided to the residents.
All physician education was provided by the physician
authors (D.W. and R.G.). A summary of the content of the
physician education is provided in Supporting Information
Appendix 2.
Nurse Education: Nurses caring for patients in the IG were
given education similar to that which was provided to the
physicians (see above), with an emphasis on practical issues
related to delivering physiologic insulin. It included topics
such as blood glucose monitoring, and the real-time manip-
ulation of nutritional insulin doses in accordance with the
clinical situation (decision-making that was specifically
delegated to the nursing staff by the order set).
Patients
Patients were eligible for inclusion in the analysis if they
met the following inclusion criteria: they were admitted to
the inpatient General Internal Medicine Services; subcutane-
ous insulin was provided to the patient during the hospitali-
zation; they had at least 2 blood glucose values >180 mg/
dL; they were discharged from the hospital on a pharmaco-
logic glucose lowering agent (insulin or oral); and their total
length-of-stay was 3 days to 14 days. Patients were excluded
from the analysis if they were admitted with a primary diag-
nosis of diabetic ketoacidosis, diabetic hyperosmolar state,
or hypoglycemia. Up to 10 consecutive days of glucose data
were recorded for each patient, and the first day on which
blood glucose information was available from the admitting
floor was excluded from the analysis. Also, specific patient-
days were not analyzed if there were no bedside glucoses
recorded, or if the patient was treated with an IV insulin
infusion on that day.
Outcomes
The primary outcome was glycemic control. The primary
unit of measure was the patient-day (ie, all of the informa-
tion for 1 patient on a single qualifying day). This was done
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to correct for the phenomenon of frequent repeat testing in
response to abnormal values. It also allows for a more clini-
cally relevant description of the actual glycemic control on
a given day. Specifically, each patient-day was categorized
as in-range (70-180 mg/dL), hyperglycemic (>180 mg/dL),
severely hyperglycemic (>250 mg/dL), hypoglycemic (<70
mg/dL), and/or severely hypoglycemic (<50 mg/dL). The
primary endpoint was glycemic control in-range. For a
patient-day to be in-range, all readings for that particular
day were within 70 mg/dL to180 mg/dL. For the readings
that were not in the desired range, a minimum of 1 deviant
reading in a particular day constituted classification into
that category, and a single out-of-range patient-day could
be included in 1 or more of the out-of-range categories (eg,
a patient-day could be categorized as both severely hyper-
glycemic and hypoglycemic if it contained glucose readings
in both of those ranges).
The day-weighted mean blood glucose value was also
calculated for each of the groups. This calculation utilized
the mean blood glucose for each patient-day, and then aver-
aged these values for each group. These metrics have been
endorsed as appropriate measures of glycemic control by
the SHM Glycemic Control Task Force.20
Other Data
Several other clinical features were also examined, including
the following: primary diagnoses listed in the hospital dis-
charge summary for each patient (3 maximum); possible
confounders including patient weight, length-of-stay, days
receiving tube feeds, days receiving parenteral nutrition,
and days during which patients were treated with high-dose
glucocorticoids (>10 mg/day of prednisone, or its equiva-
lent) or oral diabetes medications; and the composition of
the insulin regimen on each hospital day. Definitions of in-
sulin regimens are provided in Table 1.
Statistical Analysis
Bivariate analyses (chi-square, and t-tests) were carried out
to compare demographic characteristics of the intervention
and control populations. Since there were multiple glucose
readings nested within individuals, multilevel mixed-effects
logistic regression was used to evaluate the association
between the intervention and outcomes. A 2-level hierarch-
ical model was developed in which patient-days were
nested within patients; this accounted for the correlation
between glycemic control across days for a given patient.
Patient-day was modeled as a random intercept and the
log likelihood was estimated using adaptive Gaussian
quadrature with 7 integration points. Alpha was set at 0.05,
2-tailed. The final model was adjusted for gender, age,
weight, length-of-stay, use of oral diabetes agents, use of
sulfonylureas, and use of high-dose corticosteroids. The
use of a nonoral feeding route (eg, tube feeding or paren-
teral nutrition) was too infrequent to be considered in the
adjusted analysis. All analyses were conducted in Stata/IC
10.0 (College Station, TX).
Results
A total of 245 patients provided 1315 patient-days. Patient
demographics are shown in Table 2. The patients’ weight,
length-of-stay, and primary diagnoses were similar across
the 3 groups. There was a higher percentage of males in the
IG as compared to the HCG.
Table 3 shows the insulin regimens used in the different
groups. The use of basal insulin was similar between
groups. Congruent with the goals of the education session
and the order set, patients in the IG were more likely to be
treated with a combination of basal and nutritional insulin
than patients in the other groups. Patients in the HCG were
more likely to be treated with a premixed insulin than
patients in the other groups. However, even when premixed
insulin was categorized as a form of basal plus nutritional
insulin and combined into a composite group with the com-
bined basal and nutritional days, this type of regimen
remained more common in the IG than in the HCG. The
rate of sliding scale insulin use alone (ie, without any sched-
uled insulin) was similar in the 3 groups.
Other relevant measures are also shown in Table 3. The
use of oral diabetes agents was similar in the 3 groups. The
use of a nonoral feeding route (eg, tube feeding or paren-
teral nutrition) was infrequent.
TABLE 1. Definitions of the Insulin Regimens Prescribed for Each Patient-Day
Any basal insulin day Any day in which intermediate-acting or long-acting, scheduled insulin was given.
Basal insulin alone day A day in which intermediate-acting or long-acting insulin was the only scheduled insulin given.
Any nutritional insulin day Any day in which rapid-acting or short-acting, scheduled insulin was given.
Nutritional insulin alone day A day in which rapid-acting or short-acting insulin was the only scheduled insulin given.
Basal plus nutritional day A day in which both scheduled, intermediate-acting or long-acting insulin and scheduled, rapid-acting or short-acting insulin
were given.
Pre-mixed insulin day Any day in which a pre-mixed combination insulin was given.
Basal plus nutritional or pre-mixed insulin day A composite of the basal plus nutritional day category and the mixed insulin day category described above. This group
includes any day in which either a pre-mixed combination insulin was given OR a day in which both: (a) scheduled,
intermediate-acting or long-acting and (b) scheduled, rapid-acting or short-acting insulin were given.
Sliding scale insulin alone day* Any day when only correctional (as needed) insulin was given.
*Correctional insulin (also known as ‘‘sliding scale’’ or ‘‘as needed’’ insulin) was allowed as part of any insulin regimen above. Correctional insulin was only recorded when it was unaccompanied by a scheduled insulin.
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A comparison of glycemic control in the three groups is
shown in Table 4. In contrast to the CCG, patients in the IG
experienced more days within the target glucose range (17%
vs. 10.6%, P < 0.01), fewer days with severe hyperglycemia
(48.3% vs. 59.2%, P < 0.01), and had a lower day-weighted
average blood glucose (195.9 vs. 212.6, P < 0.01). Compared
to the HCG, patients in the IG experienced similar rates of
hyperglycemia, but fewer hypoglycemic days (5.1% vs. 9.2%,
P ¼ 0.02).
The percentages of patients with severe hyperglycemia in
each group are shown in Figure 1 by hospital day. Severe
hyperglycemia was common, but there was a trend towards a
decrease in the prevalence of severe hyperglycemia with
increasing hospital days for all study groups, although it was
consistently higher in the CCG than in the IG. Figure 2 shows
the types of insulin regimens used by hospital day (composite
for all groups). The use of basal plus nutritional insulin (the
recommended regimen) increased gradually with increasing
hospital days. When taken together, the information in both
figures support the hypothesis that the use of the recom-
mended insulin regimen may have contributed to the modest
improvements in glycemic control seen in the IG.
In the final adjusted regression model, the intervention
had a positive impact on glycemic control (Table 5).
TABLE 3. Insulin Regimen, Oral Diabetes Agent Use and Nutritional Information by Group
Patient-days on the following IG (n ¼ 453) CCG (n ¼ 471) P Value IG vs. CCG HCG (n ¼ 391) P Value IG vs. HCG
Sliding scale alone, n (%) 105 (23.2) 130 (27.6) 0.12 89 (22.8) 0.89
Basal alone, n (%) 132 (29.1) 231 (49.0) <0.01 199 (50.9) <0.01
Nutritional alone, n (%) 22 (4.9) 5 (1.1) <0.01 8 (2.0) 0.03
Basal plus nutritional, n (%) 166 (36.6) 71 (15.1) <0.01 14 (3.6) <0.01
Pre-mixed insulin included, n (%) 27 (6.0) 32 (6.8) 0.60 78 (20.0) <0.01
No insulin, n (%) 1 (<1) 2 (<1) 0.59 3 (<1) 0.28
Any basal, n (%) 325 (71.7) 334 (70.9) 0.78 291 (74.4) 0.38
Any nutritional, n (%) 215 (47.5) 108 (22.9) <0.01 100 (25.6) <0.01
Basal plus nutritional or pre-mixed, n (%) 193 (42.6) 103 (21.9) <0.01 92 (23.5) <0.01
Oral diabetes agents, n (%) 79 (17.4) 83 (17.6) 0.94 74 (18.9) 0.58
Sulfonylureas, n (%) 40 (8.8) 63 (13.4) 0.03 37 (9.5) 0.75
Parenteral nutrition/tube feeds, n (%) 0 (0) 18 (3.8) 8 (2.0)
High dose corticosteroids, n (%) 66 (14.6) 93 (19.8) 0.04 51 (13.0) 0.52
NOTE: Definitions of the insulin regimens are shown in Table 1.
Abbreviations: IG, intervention group; CCG, concurrent control group; HCG, historic control group.
TABLE 2. Demographic Characteristics by Group
IG CCG P Value IG vs. CCG HCG P Value IG vs. HCG
Number of patients 84 86 75
Age, years, mean (SD) 59.3 (15.3) 60.4 (15.9) 0.68 59.2 (17.2) 0.96
Range (n ¼ 245) 18-94 20-87 24-92
Weight in kg, mean (SD) 92.2 (29.5) 89.5 (27.2) 0.57 94.2 (35.4) 0.69
Range (n ¼ 237) 40-198 40-188 42-235
Sex, n (%) (n ¼ 245) 0.17 0.04
Male 45 (53.6) 37 (43.0) 28 (37.3)
Female 39(46.4) 49 (57.0) 47 (62.7)
Length of stay, mean (SD) 7.6 (3.3) 7.4 (3.0) 0.62 7.0 (2.5) 0.14
Range (n ¼ 245) 4-15 4-15 4-14
Number of diagnoses 169 158 160
Primary diagnoses, n (%) 0.56 0.10
Infections 40 (23.7) 45 (28.5) 49 (30.6)
Gastrointestinal 33 (19.5) 19 (12.0) 14 (8.8)
Rheumatologic 13 (7.7) 12 (7.6) 18 (11.2)
Renal 14 (8.3) 10 (6.3) 16 (10.0)
Diabetes-related 11 (6.5) 11 (7.0) 10 (6.2)
Neurologic 8 (4.7) 11 (7.0) 11 (6.9)
*Misc/other 50 (29.6) 50 (31.6) 42 (26.3)
Abbreviations: CCG, concurrent control group; HCG, historic control group; IG, intervention group; SD, standard deviation.
*Misc/other includes: malignancies, fluid/electrolyte, hematologic, transplant-related, cardiac, venous thromboemolism, pulmonary, and dermatologic.
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Subjects in the IG had a 72% increase in the odds of being
in the target glucose range when compared to subjects in
the CCG (P ¼ 0.01). In addition, subjects in the IG had a
35% reduction in the odds of being severely hyperglycemic
when compared to those in the CCG (P < 0.01). Finally, the
odds ratio (OR) for being hypoglycemic among intervention
subjects was 0.59 (P ¼ 0.06) when compared to subjects in
the CCG and 0.48 (P ¼ 0.01) when compared to subjects in
the HCG.
Discussion
In this study, we investigated the effects of a standardized
insulin order set, coupled with physician and nurse educa-
tion, on glycemic control in hyperglycemic hospitalized
patients. These interventions were designed to encourage a
standardized approach to the treatment of hyperglycemia in
hospitalized patients, based on the principles of physiologic
insulin use, as described above. Our data suggest that the
interventions did, indeed, alter the way insulin was pre-
scribed, as more patients in the IG received a combination
of basal plus nutritional insulin (the recommended regimen)
than in the other groups. These interventions were associ-
ated with improved glycemic outcomes in the IG as com-
pared to the CCG. The IG experienced a higher percentage
of days in the target range and a trend toward fewer hypo-
glycemic days than the CCG. Although the IG experienced a
similar percentage of days in the target range, it had signifi-
cantly fewer hypoglycemic days than the HCG.
It is useful to consider the results of our study in the
context of 2 other similar studies performed by Schnipper
et al.14 and Maynard et al.15 Although each of these 3 stud-
ies have different study designs, they are similar in intent
(to test the effects of simple quality improvement interven-
tions on glycemic control in the hospital) and results (all
showed significant improvements in some aspect of glyce-
mic control). In our study, and the study by Maynard
et al.,15 the interventions also led to decreases in the rates
of hypoglycemia, whereas Schnipper et al.14 observed no
difference in hypoglycemia. Of interest, in each of the three
studies the interventions were associated with an increase
TABLE 4. Glycemic Control by Group
IG (n ¼ 453) CCG (n ¼ 471) P Value IG vs. CCG HCG (n ¼ 391) P Value IG vs. HCG
Patient-days
In range, n (%) 77 (17.0) 50 (10.6) <0.01 66 (16.9) 0.98
Out of range, n (%) 376 (83.0) 421 (89.4) <0.01 325 (83.1) 0.98
Hyperglycemic, n (%) 289 (63.8) 310 (65.8) 0.52 248 (63.4) 0.91
Severely hyperglycemic, n (%) 219 (48.3) 279 (59.2) <0.01 176 (45.0) 0.32
Hypoglycemic, n (%) 23 (5.1) 36 (7.6) 0.11 36 (9.2) 0.02
Severely hypoglycemic, n (%) 13 (2.9) 10 (2.1) 0.47 15 (3.8) 0.44
Day weighted average blood glucose (SD) 195.9 (66.8) 212.6 (73.4) <0.01 190.5 (63.1) 0.25
NOTE: Definitions for glycemic control are provided in the text.
Abbreviations: CCG, concurrent control group; HCG, historic control group; IG, intervention group; SD, standard deviation.
FIGURE 1. Severe Hyperglycemia by hospital day.
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in the use of some type of scheduled insulin. In our study
and the study from Schnipper et al.14 the baseline use of ba-
sal insulin was quite high, and the interventions were asso-
ciated with a significant increase in the addition of nutri-
tional insulin. In the Maynard et al.15 study, the baseline use
of sliding scale insulin alone was prevalent, and the inter-
ventions resulted in an increase in the use of basal insulin.
The results of these studies, taken together, prompt us to
conclude that the interventions employed in these studies
are likely to lead to more frequent prescription of scheduled
(anticipatory) insulin, and a modest improvement in glyce-
mic control, without an increase (and perhaps with a
decrease) in hypoglycemia.
A few of our study results are unexpected, or difficult to
explain. In contrast to the other studies discussed above,
our interventions did not affect the frequency of the use of
sliding-scale insulin alone (without any scheduled insulin),
which was similar in the 3 groups. Although the reason for
this is uncertain, we hypothesize that the high baseline use
of basal insulin in our institution, and the lack of a hard
stop preventing the use of sliding scale insulin alone explain
this finding. Also, it is difficult to explain why measures of
hyperglycemia were similar between the IG and the HCG
despite the fact that the HCG was less often treated with a
combination of basal and nutritional insulin and more often
treated with mixed insulin.
There are several different mechanisms by which the
interventions might have resulted in improved glycemic
control in the IG compared to CCG. Our data clearly shows
that insulin was prescribed differently in the IG, and the
more frequent use of a combination of scheduled basal and
nutritional insulin might have contributed to the differences
between the groups. However, the effects of our interven-
tions clearly went beyond physician education into the
realm of true process improvement and standardization.
The standardized order form was designed to prompt physi-
cians to use a basal-bolus insulin regimen. The order form
also created nursing expectations of how insulin should be
ordered, and clarified the roles of the different insulins that
were prescribed.
On the medication administration record, each insulin
was labeled as basal insulin (to be given even when fasting)
TABLE 5. Multivariable Analysis of Glycemic Control
Adjusted OR* IG vs. CCG 95% CI P value IG vs. CCG Adjusted OR* IG vs. HCG 95% CI P Value IG vs. HCG
In range 1.72 1.16,2.55 0.01 1.08 0.74,1.58 0.68
Hyperglycemic 0.93 0.70,1.22 0.58 0.95 0.71,1.28 0.74
Severely Hyperglycemic 0.65 0.49,0.85 <0.01 1.10 0.82,1.47 0.52
Hypoglycemic 0.59 0.34,1.02 0.06 0.48 0.27,0.85 0.01
Severely Hypoglycemic 1.36y 0.59,3.14 0.47 0.97 0.29,1.44 0.28
Abbreviations: CCG, concurrent control group; CI, confidence interval; HCG, historic control group; IG, intervention group; OR, odds ratio.
* Adjusted for gender, age, weight, length of stay, use of oral diabetes agents, use of sulfonylureas, and use of high-dose corticosteroids.
yThis odds ratio reflects the unadjusted analysis as this model failed to converge after adjusting for the covariates.
FIGURE 2. Regimen by hospital day.
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or nutritional insulin (to be given along with the meal). The
nurses caring for the IG also attended an education program
that reinforced the role of the nurse in the bedside manage-
ment of insulin administration. Specifically, nurses were
taught to assess the premeal blood glucose and the patient’s
nutritional situation before giving the nutritional insulin (ie,
Does the patient have food available? Will he tolerate eating
the food?). In situations where is was not clear if the patient
would be able to tolerate the ordered nutrition, the order
set empowered the nurse to give the nutritional insulin after
the meal, and to reduce the dose to match the patient’s
actual intake. These interventions resulted in some funda-
mental improvements in the nursing process of delivering
insulin to the patient, and these changes might have
resulted in improvements via mechanisms that are difficult
to directly measure. Since the same physicians cared for
both the IG and the CCG, interventions other than physician
education clearly contributed to the observed improvements
in the IG.
This study was not a randomized study, and there could
be important undetected differences between the groups.
However, all of the patients were admitted to the General
Medicine Inpatient Services and the comparison of the gen-
eral patient demographics and primary diagnoses between
the groups do not suggest major differences.
Although the improvements in glycemic control seen in
this study were statistically significant, they were quantita-
tively modest. The rates of hyperglycemia seen in this study,
on the other hand, are quite remarkable. Both the American
Diabetes Association and the American College of Endocri-
nology have recommended that blood glucoses in hospital-
ized patients not exceed a maximum value of 180 mg/dL,
but the day-weighted average blood glucose in this study
was above that for each group. Even in the IG, over 80% of
all patient-days included at least 1 blood glucose value out-
side of the target range. These data suggest that better strat-
egies for achieving metabolic control in hospitalized
patients are needed.
It is worth mentioning that our interventions were not
aggressively enforced. While the use of the order set was
mandatory for the IG, it was flexible enough to allow for
substantial practice variation, especially with respect to
the dose of insulin prescribed. Although the education ses-
sions discussed the specifics of insulin dosing in hospital-
ized patients, the order form did not offer dosing guide-
lines. It is possible that our interventions may have had a
larger impact if a starting dose of insulin had been speci-
fied on the form. Although the insulin order form
prompted physicians to act, there were no forced func-
tions. Also, not all house staff attended the education
sessions for physicians, and there was no feedback pro-
vided to physicians related to how they might improve
their adherence to the recommendations presented in the
educational module. Therefore, it is likely that more
aggressive interventions could have led to greater changes
in physician practice.
In conclusion, this study demonstrates that interventions
including physician and nurse education and a standardized
insulin order set can lead to improvement in glycemic con-
trol and patient safety in hospitalized patients treated with
subcutaneous insulin. However, the observed improvements
are modest, and poor metabolic control remains common,
despite these interventions. These data suggest that stand-
ardization of the process of ordering and delivering subcuta-
neous insulin in the hospital may lead to a reduction in
both hyperglycemia and hypoglycemia. However, it is clear
that the interventions used in this study were not potent
enough to achieve the recommended glycemic targets for
the majority of patients. Additional research is needed to
determine the best strategy for achieving safe and effective
metabolic control in hospitalized, hyperglycemic, noncriti-
cally ill patients.
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